drugset / Trial / NCT04549012
Determination of Blood Loss After CS
RandomizedParallel-groupTriple-blindPrevention
Summary
Comparing betweeen tranexamic acid plus oxytocin and oxytocin alone in their efficacy in reducing blood loss following CS
Timeline
- Start
- 2020-09
- Primary completion
- 2021-09
- Completion
- 2021-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | — | — |
| Comparator | Oxytocin | Peptide | — | — |
Indications
No indication recorded.